コメント (10)
トラックバックは利用できません。
Primary renal excretion necessitates dose adjustment in patients with renal impairment.
Diflucan is used for chronic suppression in patients with recurrent mucosal infections.
Diflucan is excreted in human milk, requiring careful risk-benefit analysis during lactation.
Used for prophylaxis in high-risk solid organ transplant recipients.
Diflucan can cause taste distortion (dysgeusia) as a side effect.
Diflucan is not recommended for treatment of Pneumocystis jirovecii pneumonia.
Diflucan resistance can emerge during long-term suppressive therapy.
Serves as a benchmark for in vitro susceptibility testing of newer antifungals.
Concomitant use with calcium channel blockers can lead to excessive hypotension and edema.
Diflucan may have in vitro synergy with flucytosine against some Candida species.
Primary renal excretion necessitates dose adjustment in patients with renal impairment.
Diflucan is used for chronic suppression in patients with recurrent mucosal infections.
Diflucan is excreted in human milk, requiring careful risk-benefit analysis during lactation.
Used for prophylaxis in high-risk solid organ transplant recipients.
Diflucan can cause taste distortion (dysgeusia) as a side effect.
Diflucan is not recommended for treatment of Pneumocystis jirovecii pneumonia.
Diflucan resistance can emerge during long-term suppressive therapy.
Serves as a benchmark for in vitro susceptibility testing of newer antifungals.
Concomitant use with calcium channel blockers can lead to excessive hypotension and edema.
Diflucan may have in vitro synergy with flucytosine against some Candida species.